NEW YORK--(BUSINESS WIRE)--MabCure Inc. (OTCBB:MBCI) We are pleased to provide this update on recent important developments and on our progress in several key areas, including our ovarian cancer program, our prostate cancer program, recent financing, and the joining of our new chief scientist.
